2017;26(2):S1-S12
The Clinical Bottom Line on BPC-157 in Miami BPC-157 is a legitimately interesting recovery peptide, but it is not a product you should be buying off a website and guessing your way through
When injected, it binds to GHRH receptors on the pituitary and triggers a pulse of growth hormone release, which in turn drives the production of IGF-1 (insulin-like growth factor 1), the downstream hormone responsible for most of growth hormones tissue effects
GHK-Cu runs in 30 day cycles with a 30 day pause between them
To schedule a virtual consultation please visit www.dremilysplichal.com | Dr Emily Splichal DPM - Center for Functional & Regenerative Medicine
A comprehensive 2021 review by Seiwerth and colleagues in Frontiers in Pharmacology surveyed BPC-157 across wound healing contexts including skin, cornea, muscle, tendon, and ligament